• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury.

作者信息

Sawa H, Sobel B E, Fujii S

机构信息

Cardiovascular Division, Washington University School of Medicine, St Louis, MO 63110.

出版信息

Circ Res. 1993 Oct;73(4):671-80. doi: 10.1161/01.res.73.4.671.

DOI:10.1161/01.res.73.4.671
PMID:7690310
Abstract

Accumulation of plasminogen activator inhibitor type 1 (PAI-1) in the arterial wall may accelerate atherogenesis by inhibiting fibrinolysis, diminishing proteolysis of extracellular matrix proteins, or modifying migration of vascular smooth muscle cells. Increased intramural expression of the PAI-1 gene is induced by thrombosis. To determine whether it occurs also in response to a sustained mechanical insult to endothelium, hypercholesterolemia, or both, rabbits were subjected to sustained aortic injury induced by implantation of indwelling polyethylene tubing, to hyperlipidemia induced by cholesterol and peanut oil feeding over a period of 8 weeks, or both. Sustained vascular injury alone did not increase plasma PAI-1. However, hypercholesterolemia with or without mechanically induced vascular injury increased plasma PAI-1 twofold. The expression of PAI-1 mRNA in aorta (Northern blots) was significantly increased when vascular injury was combined with hyperlipidemia. In situ hybridization showed that the increase with mechanical injury alone occurred in endothelial cells covering the neointima (positive for factor VIII and thrombomodulin), in abnormally differentiated vascular smooth muscle cells (positive for embryonic myosin heavy chain), and in macrophages (positive for the RAM-11 anti-macrophage antibody). Qualitatively similar but much more marked increases in PAI-1 gene expression were seen when arterial injury was accompanied by hypercholesterolemia. Neither vitronectin, known to stabilize PAI-1, nor vitronectin mRNA increased in liver. However, immunocytochemistry and Western blots demonstrated marked aortic accumulation of vitronectin protein with hyperlipidemia, particularly in subendothelial fibrotic regions, accompanied by increased neointimal vitronectin mRNA as shown by in situ hybridization. These results suggest that increased synthesis and stabilization of vascular PAI-1 may potentiate accumulation of extracellular matrix, thereby accelerating atherosclerosis.

摘要

相似文献

1
Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury.
Circ Res. 1993 Oct;73(4):671-80. doi: 10.1161/01.res.73.4.671.
2
Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
J Am Coll Cardiol. 1994 Dec;24(7):1742-8. doi: 10.1016/0735-1097(94)90182-1.
3
A new butadiene derivative, T-686, inhibits plasminogen activator inhibitor type-1 production in vitro by cultured human vascular endothelial cells and development of atherosclerotic lesions in vivo in rabbits.
Thromb Res. 1997 Feb 15;85(4):305-14. doi: 10.1016/s0049-3848(97)00016-9.
4
Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis.血栓形成诱导的1型纤溶酶原激活物抑制剂在动脉壁中的表达增加。
Arterioscler Thromb. 1992 Dec;12(12):1507-15. doi: 10.1161/01.atv.12.12.1507.
5
Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta.血管紧张素转换酶抑制可抑制球囊损伤大鼠主动脉新生内膜中纤溶酶原激活物抑制剂-1的表达。
Circulation. 1996 Mar 15;93(6):1073-8. doi: 10.1161/01.cir.93.6.1073.
6
Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil.吉非贝齐对内皮细胞纤溶酶原激活物抑制剂-1表达的抑制作用。
Thromb Haemost. 1993 Oct 18;70(4):642-7.
7
Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo.体内血栓形成诱导内皮细胞表达1型纤溶酶原激活物抑制剂基因
Circulation. 1992 Dec;86(6):2000-10. doi: 10.1161/01.cir.86.6.2000.
8
Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.单核细胞/巨噬细胞纤溶酶原激活物活性表达的调节及其对血管病变减轻的影响
Circulation. 1994 Oct;90(4):1927-34. doi: 10.1161/01.cir.90.4.1927.
9
Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.血管紧张素II可增加培养的大鼠主动脉平滑肌细胞中1型纤溶酶原激活物抑制剂和组织型纤溶酶原激活物信使核糖核酸的水平。
Circulation. 1994 Jul;90(1):362-8. doi: 10.1161/01.cir.90.1.362.
10
Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.动脉粥样硬化主动脉中纤溶酶原激活物抑制剂1水平升高。
J Vasc Surg. 1996 May;23(5):810-7; discussion 817-8. doi: 10.1016/s0741-5214(96)70243-4.

引用本文的文献

1
Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.血清抗 SERPINE1 抗体作为急性脑梗死的潜在生物标志物。
Sci Rep. 2021 Nov 5;11(1):21772. doi: 10.1038/s41598-021-01176-8.
2
Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.纤溶酶原激活物抑制剂-1的化学拮抗剂:作用机制及在血管疾病中的治疗潜力
J Mol Genet Med. 2014 Oct;8(3). doi: 10.4172/1747-0862.1000125.
3
High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.
高血压合并高胆固醇血症患者中,ACE/PAI-1与一系列涉及PBMCs促炎细胞因子的其他多态性心血管基因相关的高发生率:ACE抑制剂与他汀类药物联合使用的可逆性。
PLoS One. 2015 May 14;10(5):e0127266. doi: 10.1371/journal.pone.0127266. eCollection 2015.
4
Small Molecule Targeting of PAI-1 Function: A New Therapeutic Approach for Treatment of Vascular Stenosis.靶向纤溶酶原激活物抑制剂-1功能的小分子:治疗血管狭窄的新治疗方法。
J Mol Genet Med. 2013 Jul 8;7(2). doi: 10.4172/1747-0862.1000059.
5
Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.纤溶酶原激活物抑制剂-1(PAI-1):连接纤维蛋白溶解和与年龄相关的亚临床及临床状况的关键因素。
Cardiovasc Ther. 2010 Oct;28(5):e72-91. doi: 10.1111/j.1755-5922.2010.00171.x. Epub 2010 Jul 7.
6
Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue.早期乳腺癌病变和正常乳腺组织肌上皮细胞中uPAR和PAI-1的蛋白质及mRNA表达
Br J Cancer. 2004 Aug 2;91(3):564-71. doi: 10.1038/sj.bjc.6601990.
7
Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease.纤溶酶原激活物抑制剂-1的基因多态性与冠状动脉疾病的血管造影范围相关。
J Thromb Thrombolysis. 1998 May;5(2):143-150. doi: 10.1023/A:1008882113177.
8
Dependence of Human Vascular Cell Surface Proteolysis on Expression of the Urokinase Receptor.
J Thromb Thrombolysis. 1996;3(4):331-336. doi: 10.1007/BF00133076.